Thymosin Alpha-1 vs TB-500
Side-by-side comparison of Thymosin Alpha-1, TB-500 — mechanism, dosing, half-life, side effects, and research status.
| Attribute | Thymosin Alpha-1 Thymosin Alpha-1 (Tα1) Longevity | TB-500 Thymosin Beta-4 Synthetic Analogue Recovery |
|---|---|---|
| Basics | ||
| Molecular type | Thymic Peptide | Thymic Peptide Analogue |
| Amino acids | 28 | 43 |
| Molecular weight | 3,108.4 Da | 4,921 Da |
| Half-life | ~2 hours | Long-acting (days) |
| Route(s) | Subcutaneous | Subcutaneous, Intramuscular |
| Mechanism & Research | ||
| Primary mechanism | Thymosin Alpha-1 stimulates T-cell differentiation and maturation, particularly enhancing T-helper cell (Th1) responses. This drives improved cell-mediated immunity — the arm of the immune system responsible for clearing… | TB-500's primary mechanism involves binding to G-actin (monomeric actin) through its conserved LKKTETQ sequence. By sequestering actin, it regulates cytoskeletal dynamics in ways that promote cell migration — a critical … |
| Research status | Research Compound | Research Compound |
| Evidence summary | Thymosin Alpha-1 has extensive human clinical data from its regulatory approval in Asia and Europe for viral hepatitis and cancer adjunct therapy. Longevity applications build on this established safety and immune-modula… | TB-500 research spans cardiac regeneration, wound healing, hair follicle regeneration, and musculoskeletal repair. Most data is preclinical. Phase 1/2 trials with native Thymosin Beta-4 for cardiac indications have been … |
| Protocol & Dosing | ||
| Typical dose | 1.6 mg per injection (standard clinical dose) | 5–10 mg per injection |
| Frequency | 2x per week for 6–12 weeks | 2x per week (loading), then weekly |
| Duration | 6–12 weeks | 4–8 weeks |
| Timing | Any time of day | No specific timing requirement |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Not Prohibited | Prohibited (WADA S2) |
| Deeper reading | ||
| Related peptides | Epithalon, TB-500, LL-37 | BPC-157, GHK-Cu, Thymosin Alpha-1 |
| Full profile | Read full Thymosin Alpha-1 profile → | Read full TB-500 profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.